This interview has expired.
Click here to find stocks, with exciting stories, and management committed to maximizing shareholder value.
Special deals for our readers
Are you qualified for the Visa Black Card?
The World’s Most Prestigious and Versatile Credit Card. Apply Now!
Be a more profitable investor:
What’s Jim Cramer trading in his personal portfolio? Click here
Why are you still paying too much with Schwab, and and E-trade?? Step up to the #1 discount broker: TradeKing.
Find out why TradeKing.com was ranked #1 Discount Broker by SmartMoney Magazine two years running! (August 2006 & 2007).
LifeLock is the only Identity Theft Prevention Solution backed by a one-million dollar guarantee!Click here to get a 10% discount.
Click here to get access to powerful investing tools only available at Investor’s Business Daily.
(NYSE AMEX: RPC)
Douglass MacClellan, Chairman & CEO
Radient Pharmaceuticals Corporation, formerly AMDL, Inc., is a vertically integrated specialty pharmaceutical company with three distinct business divisions that include In-Vitro diagnostics, China-based pharmaceutical manufacturing and distribution and cancer therapeutics. These business units focus on the development, manufacturing, distribution and sales of medical diagnostic products, generic pharmaceuticals, nutritional supplements, and cosmetics in the United States, China, Korea, Taiwan and other markets. The Company also has been engaged in the commercial development of and the obtaining of various governmental regulatory approvals for the marketing of its diagnostic tumor-marker test kit (DR-70) to detect the presence of multiple types of cancer. The Company operates in China through its wholly owned subsidiary, Jade Pharmaceutical Inc. (JPI).